Articles, guides, and regulatory updates from our community.
A 2026 case report links long-acting growth hormone therapy to severe DKA in a teen without prior diabetes. Learn what the research means for patients.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what the research suggests for patient safety.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
A 2026 case report reveals a child developed severe DKA after starting long-acting growth hormone therapy. Learn what clinicians and patients should know.
By Peptide Association Research Team
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team